摘要
3-羟基-3-甲戊二酰辅酶A(HMG-CoA)还原酶抑制剂(他汀)是强效的降胆固醇药,它也具有有益的抗氧化剂,抗炎,免疫调节,抗兴奋性毒性的作用。而且,他汀被证明对一些神经病具有神经保护作用,如:中风,局部脑缺血,老年痴呆,帕金森病,多发性硬化和脑外伤。相对地,关于他汀对癫痫的潜在抗惊厥作用和可能涉及的潜在保护机理的研究开展得很少。这篇综述总结了关于他汀调节癫痫发作(有时是不利的)以及在不同试验模型和临床研究中的癫痫发生的最新数据。此外,我们分析了文献中一些较普遍被报道的他汀类解痉药的相互作用的结果,我们还讨论了临床实践中遇到的一些他汀的不良反应和对他汀治疗癫痫潜在有效性的的意见。
关键词: 不良反应,阿托伐他汀,癫痫发生,氟伐他汀,洛伐他汀,普伐他汀,惊厥,辛伐他汀,他汀类抗癫痫药(AED)相互作用,他汀。
图形摘要
Current Drug Targets
Title:Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions
Volume: 16 Issue: 7
Author(s): Francesca Scicchitano, Andrew Constanti, Rita Citraro, Giovambattista De Sarro and Emilio Russo
Affiliation:
关键词: 不良反应,阿托伐他汀,癫痫发生,氟伐他汀,洛伐他汀,普伐他汀,惊厥,辛伐他汀,他汀类抗癫痫药(AED)相互作用,他汀。
摘要: 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors (statins) are potent cholesterol- lowering drugs which also possess beneficial antioxidant, antiinflammatory, immunomodulatory, and antiexcitotoxic effects. In addition, statins have proven neuroprotective effects in several neurological diseases: stroke, cerebral ischemia, Alzheimer’s and Parkinson’s disease, multiple sclerosis and traumatic brain injury. Relatively few studies have investigated the potential anti-seizure properties of statins in epilepsy and the possible underlying protective mechanisms that may be involved. This review summarizes the currently available data concerning statin effects in modulating seizure activity (sometimes adversely) and epileptogenesis in different experimental models as well as in clinical studies. Furthermore, we analyze the consequences of some of the more commonly reported statin–anticonvulsant drug interactions in the literature, discuss some of the adverse effects of statins encountered in clinical practice and comment on the potential future usefulness of statins in epilepsy therapy.
Export Options
About this article
Cite this article as:
Francesca Scicchitano, Andrew Constanti, Rita Citraro, Giovambattista De Sarro and Emilio Russo , Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions , Current Drug Targets 2015; 16 (7) . https://dx.doi.org/10.2174/1389450116666150330114850
DOI https://dx.doi.org/10.2174/1389450116666150330114850 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot Topic: Therapeutic Potential of Peptide Motifs - Part I (Executive Editor: Jean-Claude Herve)]
Current Pharmaceutical Design Microtubules (tau) as an Emerging Therapeutic Target: NAP (Davunetide)
Current Pharmaceutical Design Benzothiazoles - Scaffold of Interest for CNS Targeted Drugs
Current Medicinal Chemistry Heterocyclic Compounds as Anti-Inflammatory Agents
Current Bioactive Compounds The Interaction of DNA-Binding Ligands with Trinucleotide-Repeat DNA: Implications for Therapy and Diagnosis of Neurological Disorders
Current Topics in Medicinal Chemistry Is Mania the Hypertension of the Mood? Discussion of A Hypothesis
Current Neuropharmacology Heterotrimeric G Proteins Control Diverse Pathways of Transmembrane Signaling, a Base for Drug Discovery
Mini-Reviews in Medicinal Chemistry Non-canonical Molecular Targets for Novel Analgesics: Intracellular Calcium and HCN Channels
Current Neuropharmacology Imidazoline Receptors, Novel Agents and Therapeutic Potential
Cardiovascular & Hematological Agents in Medicinal Chemistry Interferon-γ-Induced Neurotoxicity of Human Astrocytes
CNS & Neurological Disorders - Drug Targets Models in Research of Pharmacoresistant Epilepsy: Present and Future in Development of Antiepileptic Drugs
Current Medicinal Chemistry Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Medication-precipitated Seizure in Psychiatric Patients: Typical vs. Atypical Antipsychotics
Current Psychopharmacology GABAA Receptor Channel Pharmacology
Current Pharmaceutical Design ENaC in the Brain - Future Perspectives and Pharmacological Implications
Current Molecular Pharmacology Status Epilepticus in the Immature Rodent Brain Alters the Dynamics of Autophagy
Current Neurovascular Research Gabapentin for the Treatment of Cancer-Related Pain Syndromes
Reviews on Recent Clinical Trials To Analyze the Amelioration of Phenobarbital Induced Oxidative Stress by Erucin, as Indicated by Biochemical and Histological Alterations
Anti-Cancer Agents in Medicinal Chemistry Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology Nanoemulgel: A Promising Phase in Drug Delivery
Current Pharmaceutical Design